feed,title,long_url,short_url
SeekingAlpha,Dynavax rises 4% as EMA backs marketing application for HEPLISAV-B,https://seekingalpha.com/news/3643604,
SeekingAlpha,"Vaccine from Sanofi, GSK won't be ready until late 2021",https://seekingalpha.com/news/3643603,
